|
|
|
|
FDA Objects To Claims Based On Retrospective Analysis In BenzaClin Letter
_ FDA Objects To Claims Based On Retrospective Analysis In BenzaClin Letter.
|
|
|
Sanofi Cited for Misleading DTC Patient Brochure
Sanofi-Aventis made misleading claims about its acne drug BenzaClin and omitted Sanofi Cited for Misleading DTC Patient Brochure.
|
|
|
FDA Sends Letter to Sanofi Aventis Regarding Promotion for BenzaClin
ROCKVILLE, Md., Feb.2, 2010 - The FDA today posted on its website a letter sent to Sanofi Aventis regarding a patient brochure for acne medication BenzaClin. The letter is below. DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service...
|
|
|
DDMAC letter-writers off to a busy start of 2010
The FDA's Division of Drug Marketing, Advertising and Communications got off to a busy start in January.The agency released a new batch of enforcement letters, bringing its tally for the month to nine. All were untitled letters, somewhat less serious than...
|
|
|
UPDATE: FDA Warns Sanofi, United Therapeutics On Promotional Material
(Updates with comment from Sanofi) WASHINGTON -(Dow Jones)- The U.S.Food and Drug Administration has warned Eli Lilly & Co. (LLY), United Therapeutics Corp. (UTHR) and Sanofi-Aventis SA (SNY) over misleading promotional material for some of their...
|
|
|
UPDATE FDA Warns Sanofi, United Therapeutics On... (DJ)
UPDATE: FDA Warns Sanofi, United Therapeutics On Promotional Material (Updates with comment from Sanofi) By Jared A.Favole Of DOW JONES NEWSWIRES WASHINGTON -(Dow Jones)- The U.S. Food and Drug Administration has warned Eli Lilly & Co. (LLY), United...
|
|
|
UPDATE: FDA Warns Sanofi, United Therapeutics On Promotional Material
(Updates with comment from Sanofi) WASHINGTON -(Dow Jones)- The U.S.Food and Drug Administration has warned Eli Lilly & Co. (LLY), United Therapeutics Corp. (UTHR) and Sanofi-Aventis SA (SNY) over misleading promotional material for some of their...
|
|
|
UPDATE: FDA Warns Sanofi, United Therapeutics On Promotional Material
(Updates with comment from Sanofi) WASHINGTON -(Dow Jones)- The U.S.Food and Drug Administration has warned Eli Lilly & Co. (LLY), United Therapeutics Corp. (UTHR) and Sanofi-Aventis SA (SNY) over misleading promotional material for some of their...
|
|
|
US FDA warns 3 drugmakers on misleading promotions
* FDA sends letters to Lilly, Sanofi, Meda * Videos, waiting room sign draw objections WASHINGTON, Feb 3 (Reuters) - U.S.health officials have warned Sanofi Aventis SA, Eli Lilly & Co and Meda AB about misleading promotions for prescription drugs,...
|
|
|
UPDATE FDA Warns Drug Companies On Promotional Material (DJ)
UPDATE: FDA Warns Drug Companies On Promotional Material (Updates with comments from United Therapeutic spokesman.) By Jared A.Favole Of DOW JONES NEWSWIRES WASHINGTON -(Dow Jones)- The U.S. Food and Drug Administration has warned Eli Lilly & Co. ...
|
|
|
UPDATE 1-US FDA warns 3 drugmakers on misleading promotions
* FDA sends letters to Lilly, Sanofi, Meda * Videos, waiting room sign draw objections WASHINGTON, Feb 3 (Reuters) - U.S.health officials have warned Sanofi Aventis SA <SASY.PA>, Eli Lilly & Co <LLY.N> and Meda AB <MEDAa. ST> about...
|
|
|
Reportlinker Adds The World Dermatological Market Outlook 2010-2024
NEW YORK, Jan.7 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Where will the main commercial opportunities lie in the treatment of skin disorders? Our new pharma market report explains The...
|
